BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 15945106)

  • 1. Endovascular stenting of nonmalignant superior vena cava syndrome.
    Sheikh MA; Fernandez BB; Gray BH; Graham LM; Carman TL
    Catheter Cardiovasc Interv; 2005 Jul; 65(3):405-11. PubMed ID: 15945106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benign superior vena cava syndrome: stenting is now the first line of treatment.
    Rizvi AZ; Kalra M; Bjarnason H; Bower TC; Schleck C; Gloviczki P
    J Vasc Surg; 2008 Feb; 47(2):372-80. PubMed ID: 18241760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endovascular treatment for superior vena cava occlusion or obstruction in a pediatric and young adult population: a 22-year experience.
    Tzifa A; Marshall AC; McElhinney DB; Lock JE; Geggel RL
    J Am Coll Cardiol; 2007 Mar; 49(9):1003-9. PubMed ID: 17336725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endovascular stenting as the first step in the overall management of malignant superior vena cava syndrome.
    Lanciego C; Pangua C; Chacón JI; Velasco J; Boy RC; Viana A; Cerezo S; García LG
    AJR Am J Roentgenol; 2009 Aug; 193(2):549-58. PubMed ID: 19620456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open surgical and endovascular treatment of superior vena cava syndrome caused by nonmalignant disease.
    Kalra M; Gloviczki P; Andrews JC; Cherry KJ; Bower TC; Panneton JM; Bjarnason H; Noel AA; Schleck C; Harmsen WS; Canton LG; Pairolero PC
    J Vasc Surg; 2003 Aug; 38(2):215-23. PubMed ID: 12891100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superior vena cava obstruction: diagnosis, management and outcome.
    Adegboye VO; Ogunseyinde AO; Obajimi MO; Brimmo AI; Adebo OA
    East Afr Med J; 2008 Mar; 85(3):129-36. PubMed ID: 18663886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonmalignant superior vena cava syndrome: pathophysiology and management.
    Schifferdecker B; Shaw JA; Piemonte TC; Eisenhauer AC
    Catheter Cardiovasc Interv; 2005 Jul; 65(3):416-23. PubMed ID: 15926179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical reconstruction of the superior vena cava system: indications and results.
    Picquet J; Blin V; Dussaussoy C; Jousset Y; Papon X; Enon B
    Surgery; 2009 Jan; 145(1):93-9. PubMed ID: 19081480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous stenting of the superior vena cava syndrome in a patient with cystic fibrosis.
    O'Mahony M; Skehan S; Gallagher C
    Ir Med J; 2005 Mar; 98(3):85-6. PubMed ID: 15869067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and effectiveness of vascular endoprosthesis for malignant superior vena cava syndrome.
    Nguyen NP; Borok TL; Welsh J; Vinh-Hung V
    Thorax; 2009 Feb; 64(2):174-8. PubMed ID: 19176843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endovascular therapy of superior vena cava syndrome: clinical case].
    Boza C; Mertens R; Valdés F; Kramer A; Mariné L; Vergara J
    Rev Med Chil; 2001 Apr; 129(4):421-6. PubMed ID: 11413995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous endovascular management of chronic superior vena cava syndrome of benign causes : long-term follow-up.
    Breault S; Doenz F; Jouannic AM; Qanadli SD
    Eur Radiol; 2017 Jan; 27(1):97-104. PubMed ID: 27085696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endovascular stenting for end-stage lung cancer patients with superior vena cava syndrome post first-line treatments - A single-center experience and literature review.
    Kuo TT; Chen PL; Shih CC; Chen IM
    J Chin Med Assoc; 2017 Aug; 80(8):482-486. PubMed ID: 28501315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stenting for superior vena cava obstruction in pediatric heart transplant recipients.
    Sachdeva R; Seib PM; Burns SA; Fontenot EE; Frazier EA
    Catheter Cardiovasc Interv; 2007 Nov; 70(6):888-92. PubMed ID: 17932887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of superior vena cava resection in the management of benign disease and pulmonary or mediastinal malignancies.
    Lanuti M; De Delva PE; Gaissert HA; Wright CD; Wain JC; Allan JS; Donahue DM; Mathisen DJ
    Ann Thorac Surg; 2009 Aug; 88(2):392-7. PubMed ID: 19632380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endovascular stenting in the management of malignant superior vena cava obstruction: comparing safety, effectiveness, and outcomes between primary stenting and salvage stenting.
    Leung ST; Sung TH; Wan AY; Leung KW; Kan WK
    Hong Kong Med J; 2015 Oct; 21(5):426-34. PubMed ID: 26139689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of a bloated face: SVC syndrome relieved by an endovascular approach.
    Szerlip M; Singh G; Luft UC
    J Interv Cardiol; 2012 Feb; 25(1):78-81. PubMed ID: 21599752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of the Wallstent prosthesis in the treatment of superior vena cava syndrome].
    Mae M; Oyama K; Tatebayashi T; Sakuraba M; Kanzaki M; Yoshida T; Ohnuki T; Nitta S
    Kyobu Geka; 1999 May; 52(5):395-7. PubMed ID: 10319629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perforation of the ascending aorta: a late complication of superior vena cava stenting.
    Kappert U; Schulz CG; Waldow T; Tugtekin SM; Alexiou C; Matschke K
    Thorac Cardiovasc Surg; 2006 Feb; 54(1):63-5. PubMed ID: 16485193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endovascular Management of SVC Syndrome due to Fibrosing Mediastinitis-A Feasibility and Safety Analysis.
    Majumdar S; Shoela R; Kim DJ; Ramaswamy R; Mani N; Salter A; Akinwande O
    Vasc Endovascular Surg; 2018 Apr; 52(3):202-206. PubMed ID: 29433409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.